高流量鼻导管联合上半身抬高治疗术后睡眠呼吸障碍:随机交叉试验
该单中心非盲随机交叉试验纳入23例中重度OSA患者,比较术前家庭与医院睡眠研究及术后两晚高流量鼻导管联合或不联合30度床头抬高的效果。结果显示联合干预使基于流量的呼吸暂停低通气指数较对照降低23次/小时,且改善夜间氧合,无不良事件。
要点
- 高流量鼻导管联合30度床头抬高可显著降低术后基于流量的AHI。
- 联合干预较单用高流量鼻导管额外降低AHI 12次/小时。
- 高流量鼻导管单独或联合床头抬高均改善夜间氧合且无有害事件。
核心结论
- 高流量鼻导管联合上半身抬高可降低OSA严重程度和夜间低氧血症,可能作为术后气道管理替代策略。
研究设计与样本
- 单大学医院非盲随机交叉试验,23例中重度OSA患者纳入随机,22例接受高流量鼻导管,4例退出。
- 术前在家(对照,无床头抬高)和医院(30度床头抬高)行睡眠研究;术后第一、二晚随机顺序接受高流量鼻导管联合或不联合30度床头抬高。
主要发现
- 对照基于流量的AHI为60±12次/小时(n=19)。
- 单纯30度床头抬高降低AHI 15次/小时(95%CI 6至30,P=0.002)。
- 单纯高流量鼻导管降低AHI 10.9次/小时(95%CI 1至21,P=0.028)。
- 联合干预降低AHI 23次/小时(95%CI 13至32,P<0.001)。
- 联合干预较单用高流量鼻导管额外降低AHI 12次/小时(95%CI 2至21,P=0.022)。
关键数值与推荐
- 高流量鼻导管参数为20 l·min-1、氧浓度40%。
- 床头抬高角度为30度。
- 主要结局为基于气流信号(不含血氧饱和度标准)的改良呼吸暂停低通气指数。
临床怎么用
- 对术后中重度OSA患者可考虑高流量鼻导管联合30度床头抬高以降低AHI和改善氧合。
- 该联合策略患者接受度高(22/23接受高流量鼻导管),无有害事件。
局限性
- 非盲设计,单中心,样本量小(23例随机,4例退出)。
- 主要结局基于气流信号而非血氧饱和度标准。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The low acceptance rate of continuous positive airway pressure therapy in postoperative patients with untreated obstructive sleep apnea (OSA) indicates the necessity for development of an alternative postoperative airway management strategy. The authors considered whether the combination of high-flow nasal cannula and upper-body elevation could improve postoperative OSA. METHODS: This nonblinded randomized crossover study performed at a single university hospital investigated the effect on a modified apnea hypopnea index, based exclusively on the airflow signal without arterial oxygen saturation criteria (flow-based apnea hypopnea index, primary outcome), of high-flow nasal cannula (20 l · min-1 with 40% oxygen concentration) with and without upper-body elevation in patients with moderate to severe OSA. Preoperative sleep studies were performed at home (control, no head-of-bed elevation) and in hospital (30-degree head-of-bed elevation). On the first and second postoperative nights, high-flow nasal cannula was applied with or without 30-degree head-of-bed elevation, assigned in random order to 23 eligible participants. RESULTS: Twenty-two of the 23 (96%) accepted high-flow nasal cannula. Four participants resigned from the study. Control flow-based apnea hypopnea index (mean ± SD, 60 ± 12 events · h-1; n = 19) was reduced by 15 (95% CI, 6 to 30) events · h-1 with head-of-bed elevation alone (P = 0.002), 10.9 (95% CI, 1 to 21) events · h-1 with high-flow nasal cannula alone (P = 0.028), and 23 (95% CI, 13 to 32) events · h-1 with combined head-of-bed elevation and high-flow nasal cannula (P < 0.001). Compared to sole high-flow nasal cannula, additional intervention with head-of-bed elevation significantly decreased flow-based apnea hypopnea index by 12 events · h-1 (95% CI, 2 to 21; P = 0.022). High-flow nasal cannula, alone or in combination with head-of-bed elevation, also improved overnight oxygenation. No harmful events were observed. CONCLUSIONS: The combination of high-flow nasal cannula and upper-body elevation reduced OSA severity and nocturnal hypoxemia, suggesting a role for it as an alternate postoperative airway management strategy.
引用
- Sakaguchi Y, Nozaki-Taguchi N, Hasegawa M, et al. Combination Therapy of High-flow Nasal Cannula and Upper-body Elevation for Postoperative Sleep-disordered Breathing: Randomized Crossover Trial. Anesthesiology. 2022. PMID: 35471655. doi:10.1097/ALN.0000000000004254
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。